Filing Details
- Accession Number:
- 0001384101-22-000054
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-03-09 20:46:11
- Reporting Period:
- 2022-03-03
- Accepted Time:
- 2022-03-09 20:46:11
- Original Submission Date:
- 2022-03-07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769333 | C Giulia Kennedy | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chief Scientific & Med Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-03 | 42,412 | $0.00 | 79,987 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-03-04 | 4,407 | $5.98 | 84,394 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-04 | 17,089 | $24.91 | 67,305 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-03-04 | 5,844 | $25.70 | 61,461 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-03-04 | 100 | $26.49 | 61,361 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2022-03-03 | 77,287 | $0.00 | 77,287 | $26.02 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-03-04 | 4,407 | $0.00 | 4,407 | $5.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 77,287 | 2032-03-03 | No | 4 | A | Direct | |
| 0 | 2028-03-01 | No | 4 | M | Direct |
Footnotes
- Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021.
- Represents weighted average sales price. Sale prices for the transactions range from $24.40 to $25.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $25.41 to $26.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option is fully vested.
Billionaire Hedge Funds
